HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rent, R. Articles by Gewurz, H. Search for Related Content PubMed Articles by Rent, R. Articles by Gewurz, H.

Complement Activation by Interaction of Polyanions and Polycations

I. Heparin-Protamine Induced Consumption of Complement^1,2,

Departments of Immunology and Pathology, Rush Medical College, Chicago, Illinois 60612

Abstract

Interactions of heparin and protamine in fresh human serum, in amounts far below those required for complement depletion by either agent alone, were found to induce virtually complete depletion of total hemolytic complement activity. This depletion was dependent on time, temperature, pH, divalent cations, and serum concentration. The predominant complement component hemolytic activity depleted was C1; under appropriate reaction conditions C4 and C2 were depleted as well. Equivalent amounts of heparin along induced lesser but substantial depletion of C1, potentiation of C4 and C2, and minimal depletion of C3-9, whereas equivalent amounts of protamine had no effect upon complement component activities. We conclude that interaction of heparin with protamine, like interaction of antibody with antigen, markedly enhances its ability to interact with the first component of complement and activate the classical complement pathway. It is suggested that complement activation by interactions between certain polyanions and polycations, like interactions between antigens and antibodies, may have a role in the initiation of inflammatory reactions.

Footnotes

¹ This work was presented in part to the Central Society for Clinical Investigation, November 4, 1972 (1) and to the American Association of Immunologists, April 10, 1973 (2).

² This work was supported by grants from the National Institutes of Health (5 ROI AI 10784-02 and HL 14698), the American Heart Association, the Leukemia Research Foundation and the Fay-Hunter Trust.

³ H. G. is Thomas J. Coogan, Sr., Professor and Chairman of Immunology.

This article has been cited by other articles:

				R. J. Howard, C. Crain, D. A. Franzini, C. I. Hood, and T. E. Hugli Effects of Cardiopulmonary Bypass on Pulmonary Leukostasis and Complement Activation Arch Surg, December 1, 1988; 123(12): 1496 - 1501. [Abstract] [PDF]